Scientific article
OA Policy
English

Assessing the Risk of Bias in Randomized Clinical Trials With Large Language Models

Published inJAMA network open, vol. 7, no. 5, e2412687
Publication date2024-05-01
First online date2024-05-01
Abstract

Importance: Large language models (LLMs) may facilitate the labor-intensive process of systematic reviews. However, the exact methods and reliability remain uncertain.

Objective: To explore the feasibility and reliability of using LLMs to assess risk of bias (ROB) in randomized clinical trials (RCTs).

Design, setting, and participants: A survey study was conducted between August 10, 2023, and October 30, 2023. Thirty RCTs were selected from published systematic reviews.

Main outcomes and measures: A structured prompt was developed to guide ChatGPT (LLM 1) and Claude (LLM 2) in assessing the ROB in these RCTs using a modified version of the Cochrane ROB tool developed by the CLARITY group at McMaster University. Each RCT was assessed twice by both models, and the results were documented. The results were compared with an assessment by 3 experts, which was considered a criterion standard. Correct assessment rates, sensitivity, specificity, and F1 scores were calculated to reflect accuracy, both overall and for each domain of the Cochrane ROB tool; consistent assessment rates and Cohen κ were calculated to gauge consistency; and assessment time was calculated to measure efficiency. Performance between the 2 models was compared using risk differences.

Results: Both models demonstrated high correct assessment rates. LLM 1 reached a mean correct assessment rate of 84.5% (95% CI, 81.5%-87.3%), and LLM 2 reached a significantly higher rate of 89.5% (95% CI, 87.0%-91.8%). The risk difference between the 2 models was 0.05 (95% CI, 0.01-0.09). In most domains, domain-specific correct rates were around 80% to 90%; however, sensitivity below 0.80 was observed in domains 1 (random sequence generation), 2 (allocation concealment), and 6 (other concerns). Domains 4 (missing outcome data), 5 (selective outcome reporting), and 6 had F1 scores below 0.50. The consistent rates between the 2 assessments were 84.0% for LLM 1 and 87.3% for LLM 2. LLM 1's κ exceeded 0.80 in 7 and LLM 2's in 8 domains. The mean (SD) time needed for assessment was 77 (16) seconds for LLM 1 and 53 (12) seconds for LLM 2.

Conclusions: In this survey study of applying LLMs for ROB assessment, LLM 1 and LLM 2 demonstrated substantial accuracy and consistency in evaluating RCTs, suggesting their potential as supportive tools in systematic review processes.

Keywords
  • Humans
  • Randomized Controlled Trials as Topic
  • Bias
  • Reproducibility of Results
  • Language
  • Risk Assessment / methods
Citation (ISO format)
LAI, Honghao et al. Assessing the Risk of Bias in Randomized Clinical Trials With Large Language Models. In: JAMA network open, 2024, vol. 7, n° 5, p. e2412687. doi: 10.1001/jamanetworkopen.2024.12687
Main files (1)
Article (Published version)
Secondary files (2)
Supplemental data
accessLevelPublic
Supplemental data
accessLevelPublic
Identifiers
Journal ISSN2574-3805
118views
297downloads

Technical informations

Creation23/05/2024 09:25:12
First validation11/06/2024 08:50:23
Update time11/06/2024 08:50:23
Status update11/06/2024 08:50:23
Last indexation01/11/2024 09:51:34
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack